Oloker Therapeutics
PrivateLast Round
Seed
Apr 2, 2021
Company Overview
Oloker Therapeutics is a biotechnology company that develops cellular therapies for the treatment of cardiovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
biotechnologydrug discoverysmall molecule therapeuticsoncologyinflammatory diseasespreclinical researchbiotech licensingtherapeutic candidatesdrug pipelinebiotech startuppharma partnering
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oloker Therapeutics Comparables
Compare Oloker Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Secretome Therapeutics | 69% | |
| CytoHub Inc. | 45% | |
| Pluri | 42% | |
Oloker Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 2, 2021 |
Oloker Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Siryo SpA | Seed |
Oloker Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Oloker Therapeutics's valuation, stock price, and market status.
Firmographic Details
HeadquartersBari
Employee Range5
Year Founded2021
Last FundingApr 2, 2021
See something wrong or outdated?